PITCAIRN CO - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
PITCAIRN CO ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$252,238
-2.7%
9,149
+6.0%
0.02%0.0%
Q2 2023$259,358
-17.6%
8,628
-0.7%
0.02%
-24.1%
Q1 2023$314,911
-0.4%
8,692
-2.0%
0.03%
-9.4%
Q4 2022$316,322
+1.7%
8,868
-3.6%
0.03%
-5.9%
Q3 2022$311,000
+18.7%
9,201
+1.7%
0.03%
+21.4%
Q2 2022$262,000
-10.0%
9,051
+0.6%
0.03%
+12.0%
Q1 2022$291,000
+17.8%
8,999
+6.2%
0.02%
+56.2%
Q4 2021$247,000
-49.3%
8,476
+4.2%
0.02%
-69.2%
Q2 2018$487,000
+20.0%
8,138
-8.2%
0.05%
+20.9%
Q1 2018$406,000
+20.5%
8,862
+4.6%
0.04%
+26.5%
Q4 2017$337,000
+2.7%
8,470
+3.3%
0.03%
-8.1%
Q3 2017$328,000
-7.6%
8,197
-0.5%
0.04%
-14.0%
Q2 2017$355,000
+26.3%
8,237
-8.2%
0.04%
+26.5%
Q1 2017$281,000
+19.6%
8,968
-3.6%
0.03%
+17.2%
Q4 2016$235,000
-17.5%
9,305
-19.3%
0.03%
-17.1%
Q3 2016$285,000
+17.3%
11,524
-3.4%
0.04%
+12.9%
Q2 2016$243,000
+28.6%
11,927
-3.4%
0.03%
+29.2%
Q1 2016$189,00012,3510.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders